Unknown

Dataset Information

0

Phosphorylation of the Cytoskeletal Protein CAP1 Regulates Non-Small Cell Lung Cancer Survival and Proliferation by GSK3?.


ABSTRACT: Adenylate cyclase-associated protein 1 (CAP1) is an evolutionarily conserved protein that regulates actin dynamics. Our previous study indicates that CAP1 is overexpressed in NSCLC tissues and correlated with poor clinical outcomes. Further establishing the role and dissecting underlying mechanisms are imperative before targeting CAP1 can become a possibility for cancer treatment. Here we report our findings that knockdown of CAP1 inhibited cell proliferation and induced apoptosis in vitro and in vivo. Moreover, phosphor mutants of CAP1 at the S307/S309 regulatory site had compromised rescue effects for both the invasiveness and the proliferation in CAP1-knockdown cells and GSK3? kinase inhibitor LiCl inhibited cell phosphorylation site S307/S309 by up-regulating the expression of p53, BAK, BAD and cleaved PARP induced ROS production, decreased lung cancer cell viability, adhesion, proliferation, migration and invasion, and induction of apoptosis. These novel mechanistic insights may ultimately open up avenues for strategies targeting CAP1 in the treatment of lung cancer, tailored for specific types of the highly diverse disease.

SUBMITTER: Xie S 

PROVIDER: S-EPMC6096378 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Phosphorylation of the Cytoskeletal Protein CAP1 Regulates Non-Small Cell Lung Cancer Survival and Proliferation by GSK3β.

Xie Shuanshuan S   Liu Yang Y   Li Xuan X   Tan Min M   Wang Changhui C   Field Jeffrey J   Zhou Guo-Lei GL  

Journal of Cancer 20180716 16


Adenylate cyclase-associated protein 1 (CAP1) is an evolutionarily conserved protein that regulates actin dynamics. Our previous study indicates that CAP1 is overexpressed in NSCLC tissues and correlated with poor clinical outcomes. Further establishing the role and dissecting underlying mechanisms are imperative before targeting CAP1 can become a possibility for cancer treatment. Here we report our findings that knockdown of CAP1 inhibited cell proliferation and induced apoptosis <i>in vitro</i  ...[more]

Similar Datasets

| S-EPMC8752530 | biostudies-literature
| S-EPMC4102939 | biostudies-literature
| S-EPMC3949982 | biostudies-literature
| S-EPMC4248094 | biostudies-literature
| S-EPMC4409429 | biostudies-literature
| S-EPMC4396855 | biostudies-literature
| S-EPMC3613906 | biostudies-other
| S-EPMC4905626 | biostudies-literature
| S-EPMC4680357 | biostudies-literature
| S-EPMC8122400 | biostudies-literature